Skip to content
Clinical Trials – home

PURIFIED EGG PHOSPHOLIPIDS: A Promising Treatment for Cardiac Surgery Patients and Severe Acute Pancreatitis

2 / 2
trials open to patients / all trials
3+
Countries

In short

Recent clinical trials are investigating the potential benefits of using Purified Egg Phospholipids, a component of fish oil-based lipid emulsions, in two distinct medical scenarios. One study focuses on preventing atrial fibrillation in high-risk cardiac surgery patients, while another examines its effects on reducing organ failure and mortality in severe acute pancreatitis. These trials aim to explore how this compound may improve patient outcomes in critical care settings.

What are Purified Egg Phospholipids?

Purified egg phospholipids are a component of a medical treatment known as fish oil-based lipid emulsion. This substance is derived from eggs and is used in combination with other ingredients, such as glycerol and highly refined fish oil, to create an intravenous (IV) solution. The resulting product is an emulsion for infusion, which means it's a liquid medication that can be administered directly into a patient's bloodstream.

Medical Conditions and Treatments

Purified egg phospholipids, as part of fish oil-based lipid emulsions, are being studied for their potential benefits in treating various medical conditions, including:

  • Critical illness: Patients in intensive care units (ICUs) who are critically ill.
  • Cardiac surgery: High-risk patients undergoing cardiac surgery.
  • Severe acute pancreatitis: A serious inflammation of the pancreas.

Benefits and Potential Uses

Research suggests that purified egg phospholipids, when used as part of fish oil-based lipid emulsions, may offer several potential benefits:

  1. Prevention of atrial fibrillation: One study aims to demonstrate that fish oil emulsion is superior to placebo in preventing atrial fibrillation (an irregular and often rapid heart rate) in patients after cardiac surgery.
  2. Enhanced recovery: The treatment may help patients recover more quickly after cardiac surgery.
  3. Reduction of organ failure and mortality: In patients with severe acute pancreatitis, early administration of fish oil emulsion might reduce the risk of new organ failure and death.
  4. Anti-inflammatory effects: The omega-3 fatty acids in the fish oil component may help reduce inflammation, which is a key factor in many critical illnesses.

Ongoing Clinical Trials

Two significant clinical trials are currently investigating the use of purified egg phospholipids as part of fish oil-based lipid emulsions:

  1. Cardiac Surgery Trial: This phase II multicenter trial is studying the use of intravenous fish oil-based lipid emulsion in high-risk cardiac surgery patients. The primary goal is to prevent atrial fibrillation for up to 7 days after surgery.
  2. PLANCTON Trial: This study focuses on patients with predicted severe acute pancreatitis. It aims to determine if early intravenous administration of omega-3 fatty acids can reduce new organ failure and/or mortality.

Eligibility Criteria

The eligibility criteria for these trials vary, but generally include:

  • Adult patients (18 years or older)
  • Specific medical conditions (e.g., high-risk cardiac surgery patients, predicted severe acute pancreatitis)
  • No known allergies to fish oil, egg products, or related substances
  • No severe liver or kidney dysfunction
  • No recent participation in other clinical trials

It's important to note that these criteria are specific to the clinical trials and may not reflect the eventual usage guidelines if the treatment is approved for general use.

Side Effects and Precautions

While purified egg phospholipids and fish oil-based emulsions are being studied for their potential benefits, it's important to be aware of possible side effects and precautions:

  • Allergic reactions: Patients with known hypersensitivity to fish products, egg protein, or soya products should not use these treatments.
  • Bleeding risk: Patients with severe coagulation disorders may need to avoid this treatment.
  • Liver function: Those with severe liver dysfunction may not be suitable candidates for this treatment.
  • Kidney function: Patients with severe chronic kidney dysfunction may need to avoid this treatment.

As with any medical treatment, it's crucial to consult with a healthcare professional before considering the use of purified egg phospholipids or fish oil-based emulsions. They can provide personalized advice based on your specific medical condition and health status.

Questions people often ask

Conditions where Purified Egg Phospholipids is being studied

Each condition opens its own overview and trial list

Trials with Purified Egg Phospholipids

Recruiting trials first

See all 2 →
Quick filters
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.